Chemistry:2-Bromo-4,5-methylenedioxyamphetamine

Short description: Substituted amphetamine psychedelic drug

2-Bromo-4,5-methylenedioxyamphetamine

Names
Preferred IUPAC name 1-(6-Bromo-2H-1,3-benzodioxol-5-yl)propan-2-amine
Other names 2-Bromo-4,5-methylenedioxyamphetamine 2-(2-Bromo-4,5-methylenedioxyphenyl)ethan-1-methyl-amine
Identifiers
CAS Number	151920-03-5 Y
3D model (JSmol)	Interactive image Interactive image
ChemSpider	23552998 Y
PubChem CID	44719492
UNII	N54TW884MR Y
InChI InChI=1S/C10H12BrNO2/c1-6(12)2-7-3-9-10(4-8(7)11)14-5-13-9/h3-4,6H,2,5,12H2,1H3 Y Key: PHCFFGXVMHXBGD-UHFFFAOYSA-N Y InChI=1/C10H12BrNO2/c1-6(12)2-7-3-9-10(4-8(7)11)14-5-13-9/h3-4,6H,2,5,12H2,1H3 Key: PHCFFGXVMHXBGD-UHFFFAOYAH
SMILES Brc1cc2c(OCO2)cc1CC(C)N CC(Cc1cc2c(cc1Br)OCO2)N
Properties
Chemical formula	C11H17BrNO2
Molar mass	275.166 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YN ?)
Infobox references

Tracking categories (test):

• SizeSet

2-Bromo-4,5-methylenedioxyamphetamine (6-Bromo-MDA) is a lesser-known psychedelic drug and a substituted amphetamine. It was first synthesized by Alexander Shulgin. In his book PiHKAL, the dose is listed as 350 mg and the duration unknown. It produces stimulant effects but with no psychedelic or empathogenic action. Very little data exists about its pharmacological properties, metabolism, and toxicity.

See also

• 2-Bromomescaline
• 6-Chloro-MDMA
• Phenethylamine
• Psychedelics, dissociatives and deliriants